Featured Research

from universities, journals, and other organizations

Milestone of cancer research: Arresting cancers rather than killing them

Date:
February 3, 2013
Source:
Universitaet Tübingen
Summary:
Medical researchers have shown that the immune system is able to drive tumors and tumor cells into a form of permanent dormancy. The resulting growth arrest allows tumor control in the absence of cancer cell destruction. This permanent dormancy – scientifically known as senescence – may persist for the whole life of the organism. Thus, immunotherapy can prevent tumor development without destroying the cells.

The red staining depicts former malignant tumour cells (melanoma) which were driven into permanent growth arrest, i.e. senescence, by the immune system. Tumour cells from growing melanoma do not stain red (not shown).
Credit: Image courtesy of Universitaet Tübingen

The research team of Prof. Dr. Martin Röcken from the Department of Dermatology of the University Medical Center Tübingen has shown for the first time that the immune system is able to drive tumours and tumour cells into a form of permanent dormancy (1). The resulting growth arrest allows tumour control in the absence of cancer cell destruction. This permanent dormancy -- scientifically known as senescence (2, 3) -- may persist for the whole life of the organism. Thus, immunotherapy can prevent tumour development without destroying the cells (1, 4).

Prof. Martin Röcken, Director of the Department of Dermatology of the University Medical Center Tübingen, outlines the current state of tumour therapy as follows: "About 50 years ago the former President of the United States of America Richard Nixon declared the "War on cancer." Strong financial and logistic efforts were undertaken and thought to overcome this devastating disease in relatively short time. At this time, researchers and clinicians learned to use chemotherapeutics or natural killer cells to directly attack the tumour cells and to destroy cancers including their environment. This led to several very important, partly brilliant achievements in the understanding of tumour development and to improved cancer diagnostics. What's more, the treatment of several different cancers was markedly improved by new and innovative operation techniques, radiation, chemo- and immunotherapy. However, the main goal, ie. the decisive victory on cancer, remained absent." "[For some time]," Prof. Röcken explains further, "doubts were raised about the strategy of the "War on cancer" which exclusively focussed on cancer destruction, as for example published in an essay in the journal The Lancet and other recent publications (5, 6, 7)."

Importantly, the work of the Röcken group revealed that immune responses also drive tumours of human origin into senescence. The human body apparently defends itself from cancer by inducing the senescence program in tumour cells thereby inhibiting tumour growth (1).

In this line, two well known signalling molecules of cancer therapy and immunology of infectious diseases move again in the center of attention: the interferons and tumor necrosis factor. Repeatedly, a bulk of researchers and clinicians tried to use these molecules and other techniques to destroy the tumour cells and their supplying blood vessels, and so did the scientists from Tübingen. Surprisingly, however, the Röcken group found that a combination of both signalling molecules, interferon and tumor necrosis factor, stopped the tumour growth in vivo without any signs of tumour or tissue destruction.

In animal experiments, the efficacy of immunotherapy-induced senescence proved to be much better than any other therapy based on "cancer destruction" (4). Most importantly, the common action of both signalling molecules, interferon and tumor necrosis factor, also stopped the growth of human tumours (1).

In the course of a natural immune response, the research team even detected senescence induction in regressing malignant tumours of cancer patients . Seven years ago, it was shown in principle that cancer cells can be shifted towards permanent dormancy or senescence (2, 3). Those theoretical insights were now successfully transferred into a therapeutic approach, here an immunotherapeutic regimen (1, 4).

The new therapeutic option will enable clinicians to approach their goal of a life-prolonging, mainly adverse effect-free cancer therapy. "It is very likely that we can't win the "War on cancer" by exclusive military means.," Prof. Röcken resumes. "Instead, it will be an important milestone to restore the bodies´ immune control of malignant tumours."

Notes:

1. Braumüller et al. M. T-helper-1-cell cytokines drive cancer into senescence. Nature, in press (2013).

2. Michaloglou, C. et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436, 720-724 (2005).

3. Braig, M. et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436, 660-665 (2005).

4. Müller-Hermelink, N. et al. TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis. Cancer Cell 13, 507-518 (2008).

5. Sporn, MB. The war on cancer. The Lancet 347, 1377-1381 (1996).

6. Gatenby, RA. A change of strategy in the war on cancer. Nature 459, 508-509 (2009).

7. Röcken, M. Early tumor dissemination, but late metastasis: insights into tumor dormancy. J. Clin. Invest. 120, 1800-1803 (2010).


Story Source:

The above story is based on materials provided by Universitaet Tübingen. Note: Materials may be edited for content and length.


Journal Reference:

  1. Heidi Braumüller, Thomas Wieder, Ellen Brenner, Sonja Aßmann, Matthias Hahn, Mohammed Alkhaled, Karin Schilbach, Frank Essmann, Manfred Kneilling, Christoph Griessinger, Felicia Ranta, Susanne Ullrich, Ralph Mocikat, Kilian Braungart, Tarun Mehra, Birgit Fehrenbacher, Julia Berdel, Heike Niessner, Friedegund Meier, Maries van den Broek, Hans-Ulrich Häring, Rupert Handgretinger, Leticia Quintanilla-Martinez, Falko Fend, Marina Pesic, Jürgen Bauer, Lars Zender, Martin Schaller, Klaus Schulze-Osthoff, Martin Röcken. T-helper-1-cell cytokines drive cancer into senescence. Nature, 2013; DOI: 10.1038/nature11824

Cite This Page:

Universitaet Tübingen. "Milestone of cancer research: Arresting cancers rather than killing them." ScienceDaily. ScienceDaily, 3 February 2013. <www.sciencedaily.com/releases/2013/02/130203212411.htm>.
Universitaet Tübingen. (2013, February 3). Milestone of cancer research: Arresting cancers rather than killing them. ScienceDaily. Retrieved October 23, 2014 from www.sciencedaily.com/releases/2013/02/130203212411.htm
Universitaet Tübingen. "Milestone of cancer research: Arresting cancers rather than killing them." ScienceDaily. www.sciencedaily.com/releases/2013/02/130203212411.htm (accessed October 23, 2014).

Share This



More Health & Medicine News

Thursday, October 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Working Mother (Oct. 22, 2014) — Is your child ready? Video provided by Working Mother
Powered by NewsLook.com
U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

Newsy (Oct. 22, 2014) — Now that the U.S. is restricting travel from West Africa, some are dropping questions about a travel ban and instead asking about visa bans. Video provided by Newsy
Powered by NewsLook.com
US to Track Everyone Coming from Ebola Nations

US to Track Everyone Coming from Ebola Nations

AP (Oct. 22, 2014) — Stepping up their vigilance against Ebola, federal authorities said Wednesday that everyone traveling into the US from Ebola-stricken nations will be monitored for symptoms for 21 days. (Oct. 22) Video provided by AP
Powered by NewsLook.com
Doctors Help Paralysed Man Walk Again, Patient in Disbelief

Doctors Help Paralysed Man Walk Again, Patient in Disbelief

AFP (Oct. 22, 2014) — Polish doctors describe how they helped a paralysed man walk again, with the patient in disbelief at the return of sensation to his legs. Duration: 1:04 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins